BioCentury
ARTICLE | Company News

Acura, Pfizer deal

October 1, 2012 7:00 AM UTC

Acura said Pfizer completed the return of three pain products developed using Acura's Aversion abuse-deterrent technology to Acura. In July, the pharma exercised its right to return the products, whi...